Akorn exits vaccine distribution business Akorn, Inc få beskrivelsen . The existing supply agreement shall end on March 14, 2010. The company announced its intent to exit the distribution of flu vaccines. In addition, the Td vaccine business created excessive economic burden on the ongoing company since its start and is expected to contribute and then operating profits in ’09 2009 marginally. Exiting the vaccine distribution business allows our sales force to focus on new product launches and on higher margin items. We expect a soft transition of the Td vaccine business and will continue steadily to support our existing customer needs through our supply chain.